Combination of tigecycline and N-acetylcysteine reduces biofilm-embedded bacteria on vascular catheters
about
Biofilm and Helicobacter pylori: from environment to human hostBiofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics.Nitazoxanide inhibits biofilm formation by Staphylococcus epidermidis by blocking accumulation on surfaces.Mechanical integrity of hemodialysis catheters after exposure to a novel catheter lock solutionRole of antibiofilm-antimicrobial agents in controlling device-related infections.Modality of bacterial growth presents unique targets: how do we treat biofilm-mediated infections?N-acetyl cysteine as an adjunct to standard anti-Helicobacter pylori eradication regimen in patients with dyspepsia: A prospective randomized, open-label trial.Daptomycin and tigecycline have broader effective dose ranges than vancomycin as prophylaxis against a Staphylococcus aureus surgical implant infection in miceN-acetylcysteine lock solution prevents catheter-associated bacteremia in rabbitsIn Vivo Efficacy of a "Smart" Antimicrobial Implant Coating.Foreign body infections due to Staphylococcus epidermidis.Staphylococcus epidermidis device-related infections: pathogenesis and clinical management.Outcome of acute prosthetic joint infections due to gram-negative bacilli treated with open debridement and retention of the prosthesisMini-review: Antimicrobial central venous catheters--recent advances and strategies.Review article: biofilm formation by Helicobacter pylori as a target for eradication of resistant infection.Antibiofilm agents and implant-related infections in orthopaedics: where are we?Mini-review: Staphylococcus epidermidis as the most frequent cause of nosocomial infections: old and new fighting strategies.Interplay of infections, autoimmunity, and immunosuppression in systemic lupus erythematosus.History and evolution of antibiotic resistance in coagulase-negative staphylococci: Susceptibility profiles of new anti-staphylococcal agents.Drug treatments for prosthetic joint infections in the era of multidrug resistance.Synergy of ultrasound microbubbles and vancomycin against Staphylococcus epidermidis biofilm.Tigecycline: Alone or in combination?Evaluation of combinations of putative anti-biofilm agents and antibiotics to eradicate biofilms of Staphylococcus aureus and Pseudomonas aeruginosa.Emergency 1-stage anterior approach for cervical spine infection complicated by epidural abscess.Effect of different agents with potential antibiofilm activity on antimicrobial susceptibility of biofilms formed by Staphylococcus spp. isolated from implant-related infections.Comparative in vitro efficacies of various antipseudomonal antibiotics based catheter lock solutions on eradication of Pseudomonas aeruginosa biofilms.Farnesol in combination with N-acetylcysteine against Staphylococcus epidermidis planktonic and biofilm cells.Effects of vancomycin, daptomycin, and tigecycline on coagulase-negative staphylococcus biofilm and bacterial viability within biofilm: an in vitro biofilm model.Evaluation of antimicrobial activity of certain combinations of antibiotics against in vitro Staphylococcus epidermidis biofilms.Does dithiothreitol improve bacterial detection from infected prostheses? A pilot study.Bacterial translocation across ePTFE vascular graft surfacesEfficacy of acidic and basic electrolyzed water in eradicating Staphylococcus aureus biofilm.Efficacy of combination of N-acetylcysteine, gentamicin, and amphotericin B for prevention of microbial colonization of ventricular assist devices.Pilot trial of N-acetylcysteine and tigecycline as a catheter-lock solution for treatment of hemodialysis catheter-associated bacteremia.Antimicrobial and Antibiofilm Activity of Human Milk Oligosaccharides against Streptococcus agalactiae, Staphylococcus aureus, and Acinetobacter baumannii.Investigation of the effects of various antibiotics against Klebsiella pneumoniae biofilms on in vitro catheter model.Activity of Amphotericin B and Anidulafungin Combined with Rifampicin, Clarithromycin, Ethylenediaminetetraacetic Acid, N-Acetylcysteine, and Farnesol against Candida tropicalis Biofilms.Biological Activities and Potential Oral Applications of N-Acetylcysteine: Progress and Prospects.In vitro effects of N-acetylcysteine alone and combined with tigecycline on planktonic cells and biofilms of Acinetobacter baumannii.
P2860
Q27015096-D1F5384E-B4ED-4C23-B3DF-DA3971378BBCQ30403958-4042A2FF-24EA-4A19-90AD-487F67E6FF5CQ30433594-B114718C-B052-42F3-916D-287D175809F7Q33696391-6482AF8A-FF8A-4D7B-A47A-B5638F207F8BQ34077214-A2EBCDA6-16A3-481B-AE62-066483DF2061Q34252915-AF57E2E0-CA9B-4EBA-8ED3-2AE32D85BEA0Q34304343-9B32ECCA-AC67-4487-B027-D7C26683B0E3Q35941476-2424BB35-3ADC-4E0A-84F3-13497D834DDAQ37116666-5826CF58-60E7-488A-853F-52C174C28B54Q37197429-5FC7D789-A618-4906-8803-D9AFAB65C819Q37249440-9495431E-20A1-4688-A0C4-593979A44274Q37322685-E6921307-D347-4CD2-9D7E-B37CDBEA0A24Q37409869-1FB4567B-4AAE-4B49-931B-CDEDF45508BEQ37896090-2D87EF9B-1F5A-4CFF-86C0-303F39BFDFC0Q38014922-35BC4FE7-0984-4AFE-A929-50D683B6C8DEQ38107655-FB638D1B-AE25-4C82-9899-50452A71C771Q38166786-5B0F0BFC-8998-430E-926B-2E0BAC682016Q38182646-512113B9-CE4C-4D0B-90E9-2D64322D6946Q38536137-4A1AEC16-52CE-4064-B015-90677D28CB2FQ38800556-BA284698-F459-4660-95FD-28870A203527Q39501793-20244A2B-BC0C-429E-833C-7FD46343C3B3Q39916184-F811C163-2B37-4456-A7BE-12D6CF224BC6Q40072216-519DEEED-5855-4C42-91C2-2448BC73A341Q40154965-DA9235E7-6153-4915-979D-75F7D7380B87Q40780892-ADAE0A98-D979-40C7-B867-D576A2365865Q41725795-6BF71654-DDF1-4347-8378-DC5DCEA89CF8Q41838275-0C1B6578-02DE-4BBC-8293-88F0810A53D3Q42103662-FAFFE68E-4660-4131-B808-345FED342EE7Q42218026-4E3BDCA1-42DE-41E1-9290-681A6A4A1A11Q42325197-87F139E6-8F36-4B22-AF93-AAC76E075A5FQ42592964-A03052CA-3320-4D80-8216-7301DFD2C70FQ44522479-CF00A335-3925-4B6D-BEEE-B5EAFB2C0A6AQ46193541-0AEDD897-C103-42EB-BD02-2BFC25D5AE62Q46471711-D6F5247A-2708-4B73-A24D-E8C7BEA00164Q47689699-B125ED36-B333-4AAF-AAAA-AB0364695583Q48139465-CDEF4F8A-ED12-427A-ABF2-4B043F3895C9Q48523183-7B42FD35-7DBB-4371-BB4D-19854F7F73BDQ54698100-AC0F9D59-03B0-4080-AAC9-FE30584B0D82Q55266091-826F2234-741D-4F17-8A96-B0542D531120
P2860
Combination of tigecycline and N-acetylcysteine reduces biofilm-embedded bacteria on vascular catheters
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Combination of tigecycline and ...... bacteria on vascular catheters
@en
Combination of tigecycline and ...... bacteria on vascular catheters
@nl
type
label
Combination of tigecycline and ...... bacteria on vascular catheters
@en
Combination of tigecycline and ...... bacteria on vascular catheters
@nl
prefLabel
Combination of tigecycline and ...... bacteria on vascular catheters
@en
Combination of tigecycline and ...... bacteria on vascular catheters
@nl
P2093
P2860
P356
P1476
Combination of tigecycline and ...... bacteria on vascular catheters
@en
P2093
Barbara W Trautner
Rabih O Darouiche
Saima Aslam
Venkat Ramanathan
P2860
P304
P356
10.1128/AAC.00893-06
P407
P577
2007-01-12T00:00:00Z